Laronde
Latest round
- Series B
Last raised
- Aug 2021
Total raised
- $471M
Investors
- 7
About Laronde
Based in Massachusetts, US, and founded in 2017 by founder and CEO Noubar Afeyan and Avak Kahvejian, the Laronde Inc. platform offers a way of modulating human biology. In August 2021, Laronde Inc., Invus, CPP Investments, Fidelity Management & Research Company, BlackRock, and Federated Hermes Kaufmann Funds. Laronde Inc. offers eRNA-based non-immunogenic therapeutics supported by a digital and manufacturing infrastructure that can be programmed to express diverse proteins inside the body. Laronde Inc.
Who invested in Laronde
7 investors across 2 rounds
See all investors in Laronde
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Laronde
Who invested in Laronde?
Laronde has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Laronde raised?
Laronde has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Laronde last raise money?
Laronde's most recent round on record is a Series B, in Aug 2021.
What does Laronde do?
Based in Massachusetts, US, and founded in 2017 by founder and CEO Noubar Afeyan and Avak Kahvejian, the Laronde Inc.
Where is Laronde headquartered?
Laronde is headquartered in Cambridge, US.
Which VCs invest in companies like Laronde?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Laronde's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Laronde? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.